ELVN
#1663
Enliven Therapeutics, Inc. - Common Stock
40.8 4 USD
0.00%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-0.34%
Variación mensual
-25.75%
Variación en los últimos 6 meses
-7.31%
Cambio anual
+97.68%
Cierres anteriores
40.9 8
Open
40.6 7
Mínimo
40.5 0
Máximo
41.4 1
Financials
- Market Capitalization 2.99 B
- Employee 67
- Founded 2016
- CEO N/A
- Website www.enliventherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00CP3BDD4
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-8.42
Relación precio/flujo de caja
-8 232.35
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1642 |  AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 27.48 USD | -2.35% | -1.75% | -13.69% | +95.59% | 3.06 B USD | ||
| 1651 |  DNLI Denali Therapeutics Inc. - Common Stock | 18.95 USD | -2.57% | -4.92% | -10.15% | +17.19% | 3.03 B USD | ||
| 1667 |  DYN Dyne Therapeutics, Inc. - Common Stock | 15.96 USD | -4.09% | +2.97% | -13.26% | -31.82% | 2.98 B USD | ||
| 1722 |  ZLAB Zai Lab Limited - American Depositary Shares | 24.59 USD | -1.60% | -8.25% | +1.40% | -7.87% | 2.76 B USD |